Legal Representation
Attorney
Patricia A Walker
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2007 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jul 7, 2007 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 7, 2006 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Dec 6, 2006 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jun 5, 2006 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Jun 3, 2006 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 9, 2006 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Feb 8, 2006 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| May 5, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 11, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 11, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 8, 2006 | I | PAPER RECEIVED | Loading... | |
| Jan 9, 2006 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Jan 7, 2006 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jun 24, 2005 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Jun 23, 2005 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 23, 2005 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 6, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 6, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 13, 2004 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Dec 11, 2004 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Dec 11, 2004 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| May 24, 2004 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| May 8, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 8, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 12, 2003 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Oct 21, 2003 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Apr 10, 2003 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Feb 7, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 7, 2003 | I | PAPER RECEIVED | Loading... | |
| Oct 28, 2002 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Oct 15, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 23, 2002 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Oct 19, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 20, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Mar 29, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
celltherapeutic and stemcell transplant diagnostic preparations for scientific and research; regenerative cell, tissue, and organic preparations for scientific and research use; and clinical testing preparations, namely, preparations from stemcells or differentiated and modified stemcells for scientific and research use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
pharmaceutical cell preparations as human medicine, namely, for use in the treatment of diseases such as but not limited to degenerative diseases of the liver (eg. cirrhosis), heart (eg. infarct, congestive heart failure), brain and spine (eg. Parkinson's disease, stroke, paralysis, spinal injuries), bone (eg. tumor resections, degenerative bone disease), cartilage (eg. meniscal tears, vertebral discs), pancreas (type I diabetes), vascular disease, degenerative muscle diseases and for hematopoietic reconstitution after cancer treatment; celltherapeutic and stemcell transplant diagnostic preparations for clinical and medical laboratory use; celltherapeutic and stemcell transplant diagnostic reagents; Adjuvant substance for the stemcell therapy; regenerative cell, tissue, and organic preparations for clinical or medical laboratory use; medical reagents, namely, regenerative cell, tissue and organic reagents; stemcells or differentiated and modified stemcell preparations for clinical and medical laboratory use; and medical reagents, namely, stemcells and differentiated and modified stemcell reagents
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005